Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416555 · ClinicalTrials.gov registry record · NA
Virtual Reality Distraction for Reduction
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT04416555 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 113 participants.
The verdict
NCT04416555, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
Using a randomized controlled design, the investigators goal is to estimate the effect of VR on postoperative analgesia and opioid consumption.
Interventions
- DEVICE Placebo comparator: VR googles and the non reality experience
- DEVICE Active Comparator: VR googles and the real VR program to enter act with and experience
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2022-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04416555
The ClinicalTrials.gov registry entry for NCT04416555 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo comparator: VR googles and the non reality experience is the first listed.
NCT04416555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04416555 about?
NCT04416555 is a clinical study titled "Virtual Reality Distraction for Reduction". Using a randomized controlled design, the investigators goal is to estimate the effect of VR on postoperative analgesia and opioid consumption.
What is the current status of trial NCT04416555?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2020-08-03. Estimated completion is 2022-05-03.
What interventions are being tested in trial NCT04416555?
The interventions under investigation include: Placebo comparator: VR googles and the non reality experience (DEVICE), Active Comparator: VR googles and the real VR program to enter act with and experience (DEVICE).
Who is sponsoring clinical trial NCT04416555?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.